Valuation: CTT Pharmaceutical Holdings, Inc.

Market Cap 3.28M 2.92M 2.73M 2.47M 4.67M 317M 4.7M 32.77M 12.75M 162M 12.33M 12.07M 519M P/E 2024
-11.9x
P/E 2025 -22.2x
Enterprise Value 3.29M 2.92M 2.73M 2.48M 4.68M 317M 4.71M 32.81M 12.76M 162M 12.34M 12.08M 520M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
50.43%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member 71 09/09/2014
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-22.52%-0.09% - - 3.28M
+4.16%+3.42%+49.37%+94.17% 74.31B
+2.76%-1.60%+22.80%+78.53% 56.95B
+0.24%-1.34%+3.41%+34.31% 48.3B
-4.04%-2.06%+329.93%+699.76% 44.51B
-0.88%-1.76%+28.89%+33.03% 43.8B
+1.25%+0.02%+6.04%+110.10% 41.12B
-0.11%+2.30%+9.19%+58.68% 31.07B
+4.51%+8.43%+37.27%+34.97% 28.97B
-1.07%-0.76%-6.98%-12.04% 24.53B
Average -1.56%-0.20%+53.32%+125.72% 43.73B
Weighted average by Cap. +1.06%-0.50%+57.24%+134.14%

Financials

2024 2025
Net sales - -
Net income -250K -222K -208K -188K -356K -24.12M -358K -2.5M -971K -12.31M -939K -919K -39.56M -156K -138K -130K -117K -222K -15.03M -223K -1.56M -605K -7.67M -585K -573K -24.65M
Net Debt 16.82K 14.93K 13.97K 12.66K 23.92K 1.62M 24.09K 168K 65.27K 827K 63.13K 61.78K 2.66M 3.46K 3.07K 2.87K 2.6K 4.91K 333K 4.95K 34.47K 13.41K 170K 12.97K 12.69K 546K
Logo CTT Pharmaceutical Holdings, Inc.
CTT Pharmaceutical Holdings, Inc. specializes in drug delivery systems technology within the pharmaceutical industry. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. It rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. It offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. It is a thin film for treating dogs and cats.
Employees
-